SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. (not Streamex Corp.) on November 13, 2019. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The filing serves as a Regulation FD disclosure regarding a shareholder letter issued on the same date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a shareholder communication and does not contain a financial statement or quarterly results.
Material Changes
No material financial changes versus prior periods are detailed in this document. The primary event reported is the issuance of a letter to shareholders (Exhibit 99.1).
Guidance, Outlook, and Risks
- Management Commentary: The Company issued a letter to shareholders attached as Exhibit 99.1.
- Forward-Looking Statements: The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials in the shareholder letter.
- Legal Status: The information in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
- Materiality: The Company notes that furnishing this information is not intended to constitute a determination that the information is material or required by Regulation FD.
Investor Verification Checklist
- Review Exhibit 99.1 (Shareholder Letter, November 2019) for the specific content of the communication, as the 8-K body only references its existence.
- Verify the current trading status and ticker symbol (BSGM) on the NASDAQ Capital Market.
- Confirm the identity of the registrant as BioSig Technologies, Inc., noting the discrepancy with the requested company name "Streamex Corp."
- Check subsequent filings for any updates to the shareholder letter, as the Company disclaimed any obligation to update the information.